
Last Posted: Dec 21, 2020
- [Impact of the inclusion of second-tier tests in the newborn screening program of Catalonia and in other international programs.]
Pajares García Sonia et al. Revista espanola de salud publica 2020 Dec 94 - [Response of the Catalonia neonatal screening laboratory to the pandemic of SARS-CoV-2.]
Argudo Ramírez Ana et al. Revista espanola de salud publica 2020 Dec 94 - Characterizing Pharmacogenetic Testing Among Children's Hospitals.
Brown Jacob T et al. Clinical and translational science 2020 Dec - Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors.
Takeda Masayuki et al. The oncologist 2020 Dec - Clinician involvement in research on machine learning-based predictive clinical decision support for the hospital setting: A scoping review.
Schwartz Jessica M et al. Journal of the American Medical Informatics Association : JAMIA 2020 Dec - Desiderata for delivering NLP to accelerate healthcare AI advancement and a Mayo Clinic NLP-as-a-service implementation.
Wen Andrew et al. NPJ digital medicine 2019 Dec 2(1) 130 - Pharmacist Consult Reports to Support Pharmacogenomics Report Interpretation.
Bright David et al. Pharmacogenomics and personalized medicine 2020 13719-724 - Philippine Performance Evaluation and Assessment Scheme (PPEAS): Experiences in Newborn Screening System Quality Improvement.
Padilla Carmencita D et al. International journal of neonatal screening 2020 Dec 6(4) - Prenatal array comparative genomic hybridization in a well-defined cohort of high-risk pregnancies. A three-year implementation results in a public tertiary academic referral hospital.
Tanner Laura M et al. Prenatal diagnosis 2020 Dec - Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients.
Ramsey Laura B et al. JAMA network open 2020 Dec 3(12) e2029411
Search Result Summary
- CDC Information (20)
- NIH Information (22)
- CDC Publications (23)
- Human Genome Epidemiologic Studies (292)
- GWAS Studies (5)
- Human Genomics Translation/Implementation Studies (1267)
- Genomic Tests Evidence Synthesis (122)
- Genomic Tests Guidelines (98)
- Tier-Classified Guidelines (41)
- Non-Genomics Precision Health (570)
- Pathogen Advanced Molecular Detection (41)
- State Public Health Genomics Programs (33)
- Ethical/Legal and Social Issues (ELSI) (75)
Quick Links to Other Resources
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2020
- Page last updated:Dec 28, 2020
- Content source:

